Non Hodgkin Lymphoma Clinical Trial
Long-term Follow-up Study of Patients Receiving CAR-T Cells
Summary
This protocol is designed as a long-term follow-up study of participants who will receive genetically modified autologous CAR-T cells as part of clinical trial at the Medical College of Wisconsin/ Froedtert Hospital-- Phase 1 Study of CAR-20/19-T Cells in Patients with Relapsed Refractory B Cell Malignancies (NCT03019055).
Full Description
The objective is to follow participants receiving CAR-T cells from years 2 to 15 post-treatment for persistence of CAR-T cells, development of secondary malignancies, or other medical complications.
Eligibility Criteria
Inclusion Criteria:
All participants who enrolled in a CAR-T study at Froedtert Hospital & the Medical College of Wisconsin.
Exclusion Criteria:
There are no exclusion criteria for this study.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Milwaukee Wisconsin, 53226, United States More Info
How clear is this clinincal trial information?